150 related articles for article (PubMed ID: 38519141)
1. CXCR4: from B-cell development to B cell-mediated diseases.
Giorgiutti S; Rottura J; Korganow AS; Gies V
Life Sci Alliance; 2024 Jun; 7(6):. PubMed ID: 38519141
[TBL] [Abstract][Full Text] [Related]
2. CXCR4-Specific Nanobodies as Potential Therapeutics for WHIM syndrome.
de Wit RH; Heukers R; Brink HJ; Arsova A; Maussang D; Cutolo P; Strubbe B; Vischer HF; Bachelerie F; Smit MJ
J Pharmacol Exp Ther; 2017 Oct; 363(1):35-44. PubMed ID: 28768817
[TBL] [Abstract][Full Text] [Related]
3. WHIM syndrome: Immunopathogenesis, treatment and cure strategies.
McDermott DH; Murphy PM
Immunol Rev; 2019 Jan; 287(1):91-102. PubMed ID: 30565238
[TBL] [Abstract][Full Text] [Related]
4. Adaptive Immunodeficiency in WHIM Syndrome.
Majumdar S; Murphy PM
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577453
[TBL] [Abstract][Full Text] [Related]
5. WHIM syndrome: congenital immune deficiency disease.
Kawai T; Malech HL
Curr Opin Hematol; 2009 Jan; 16(1):20-6. PubMed ID: 19057201
[TBL] [Abstract][Full Text] [Related]
6. Altered leukocyte response to CXCL12 in patients with warts hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome.
Gulino AV; Moratto D; Sozzani S; Cavadini P; Otero K; Tassone L; Imberti L; Pirovano S; Notarangelo LD; Soresina R; Mazzolari E; Nelson DL; Notarangelo LD; Badolato R
Blood; 2004 Jul; 104(2):444-52. PubMed ID: 15026312
[TBL] [Abstract][Full Text] [Related]
7. A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome.
McDermott DH; Velez D; Cho E; Cowen EW; DiGiovanna JJ; Pastrana DV; Buck CB; Calvo KR; Gardner PJ; Rosenzweig SD; Stratton P; Merideth MA; Kim HJ; Brewer C; Katz JD; Kuhns DB; Malech HL; Follmann D; Fay MP; Murphy PM
J Clin Invest; 2023 Oct; 133(19):. PubMed ID: 37561579
[TBL] [Abstract][Full Text] [Related]
8. IL-7 receptor signaling drives human B-cell progenitor differentiation and expansion.
Kaiser FMP; Janowska I; Menafra R; de Gier M; Korzhenevich J; Pico-Knijnenburg I; Khatri I; Schulz A; Kuijpers TW; Lankester AC; Konstantinidis L; Erlacher M; Kloet S; van Schouwenburg PA; Rizzi M; van der Burg M
Blood; 2023 Sep; 142(13):1113-1130. PubMed ID: 37369082
[TBL] [Abstract][Full Text] [Related]
9. CXCL12/CXCR4 Axis Drives the Chemotaxis and Differentiation of B Cells in Bullous Pemphigoid.
Fang H; Xue K; Cao T; Li Q; Dang E; Liu Y; Zhang J; Qiao P; Chen J; Ma J; Shen S; Pang B; Bai Y; Qiao H; Shao S; Wang G
J Invest Dermatol; 2023 Feb; 143(2):197-208.e6. PubMed ID: 36075452
[TBL] [Abstract][Full Text] [Related]
10. Disease Progression of WHIM Syndrome in an International Cohort of 66 Pediatric and Adult Patients.
Geier CB; Ellison M; Cruz R; Pawar S; Leiss-Piller A; Zmajkovicova K; McNulty SM; Yilmaz M; Evans MO; Gordon S; Ujhazi B; Wiest I; Abolhassani H; Aghamohammadi A; Barmettler S; Bhar S; Bondarenko A; Bolyard AA; Buchbinder D; Cada M; Cavieres M; Connelly JA; Dale DC; Deordieva E; Dorsey MJ; Drysdale SB; Ehl S; Elfeky R; Fioredda F; Firkin F; Förster-Waldl E; Geng B; Goda V; Gonzalez-Granado L; Grunebaum E; Grzesk E; Henrickson SE; Hilfanova A; Hiwatari M; Imai C; Ip W; Jyonouchi S; Kanegane H; Kawahara Y; Khojah AM; Kim VH; Kojić M; Kołtan S; Krivan G; Langguth D; Lau YL; Leung D; Miano M; Mersyanova I; Mousallem T; Muskat M; Naoum FA; Noronha SA; Ouederni M; Ozono S; Richmond GW; Sakovich I; Salzer U; Schuetz C; Seeborg FO; Sharapova SO; Sockel K; Volokha A; von Bonin M; Warnatz K; Wegehaupt O; Weinberg GA; Wong KJ; Worth A; Yu H; Zharankova Y; Zhao X; Devlin L; Badarau A; Csomos K; Keszei M; Pereira J; Taveras AG; Beaussant-Cohen SL; Ong MS; Shcherbina A; Walter JE
J Clin Immunol; 2022 Nov; 42(8):1748-1765. PubMed ID: 35947323
[TBL] [Abstract][Full Text] [Related]
11. Asymmetrical forward and reverse developmental trajectories determine molecular programs of B cell antigen receptor editing.
Okoreeh MK; Kennedy DE; Emmanuel AO; Veselits M; Moshin A; Ladd RH; Erickson S; McLean KC; Madrigal B; Nemazee D; Maienschein-Cline M; Mandal M; Clark MR
Sci Immunol; 2022 Aug; 7(74):eabm1664. PubMed ID: 35930652
[TBL] [Abstract][Full Text] [Related]
12. CXCR4 as a novel target in immunology: moving away from typical antagonists.
Caspar B; Cocchiara P; Melet A; Van Emelen K; Van der Aa A; Milligan G; Herbeuval JP
Future Drug Discov; 2022 Jun; 4(2):FDD77. PubMed ID: 35875591
[TBL] [Abstract][Full Text] [Related]
13. Integrated single cell and spatial transcriptomics reveal autoreactive differentiated B cells in joints of early rheumatoid arthritis.
Hardt U; Carlberg K; Af Klint E; Sahlström P; Larsson L; van Vollenhoven A; Hernandez Machado S; Israelsson L; Amara K; Chemin K; Korotkova M; Karlsson Hedestam GB; Catrina AI; Teichmann SA; Ståhl PL; Malmström V
Sci Rep; 2022 Jul; 12(1):11876. PubMed ID: 35831338
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
